Page last updated: 2024-11-10

2-hexadecenal

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

trans-hexadec-2-enal : A hexadecenal containing a double bond at position 2 (the trans-stereoisomer). [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

hexadecenal : A monounsaturated fatty acid aldehyde that is hexadecanal which has undergone formal dehydrogenation to introduce a double bond at unspecified position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5280541
CHEBI ID17585
SCHEMBL ID1783148
MeSH IDM0509790

Synonyms (28)

Synonym
CHEBI:17585
(2e)-hexadec-2-enal
trans-hexadec-2-enal
(2e)-hexadecenal
2-hexadecenal, e
(e)-2-hexadecenal
hexadecenal
C06123 ,
2-trans-hexadecenal
LMFA06000089
2-hexadecenal
hexadec-2-enal
2-(d5)-hexadecenal
2-(15,15,16,16,16-d5)-hexadecenal
3163-37-9
z79h35z0ru ,
unii-z79h35z0ru
(e)-hexadec-2-enal
27104-14-9
trans-2-hexadecenal
22644-96-8
SCHEMBL1783148
2-hexadecenal, (2e)-
2-hexadecenal, (e)-
J-014797
16:1 aldehyde, (2e)-hexadecenal, powder
Q27102466
DTXSID801015907
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
hexadecenalA monounsaturated fatty acid aldehyde that is hexadecanal which has undergone formal dehydrogenation to introduce a double bond at unspecified position.
trans-2,3-unsaturated fatty aldehydeA fatty aldehyde with a trans-double bond at carbon 2.
n-alk-2-enalAn enal obtained by formal dehydrogenation across positions 2 and 3 of any n-alkanal
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (8)

PathwayProteinsCompounds
Metabolism14961108
Metabolism of lipids500463
Sphingolipid metabolism5550
Sphingolipid metabolism overview415
Synthesis of ceramides and 1-deoxyceramides115
Sphingolipid catabolism814
sphingosine and sphingosine-1-phosphate metabolism1120
Sphingolipids metabolism pathway063

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (10.00)29.6817
2010's5 (50.00)24.3611
2020's4 (40.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.91

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.91 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index5.47 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.91)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (8.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]